Pre-investment diligence
Scientific credibility, formulation defensibility, quality systems, claims, regulatory exposure, supply concentration and scale readiness.
PE & Board Advisory
See the technical risk before it becomes an investment problem.
Independent review for private equity, boards, strategic buyers and portfolio companies across beauty, wellness, consumer health, ingredients and biotechnology.
Value-creation plan
Innovation pipeline, margin architecture, portfolio focus, premiumization, R&D productivity and leadership capability.
Post-acquisition integration
Operating model, decision rights, technical transfer, supplier strategy, quality governance and talent continuity.
Board oversight
Capital allocation, risk, innovation governance, ESG, technology and long-term enterprise value.
Institutional application gateway
Board, investor and PE enquiries are reviewed through an application route, not a paid discovery-call gate.